✦ LIBER ✦

Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?

✍ Scribed by Stephan Kersting; Ralf Konopke; Dag Dittert; Marius Distler; Felix Rückert; Jörg Gastmeier; Gustavo B Baretton; Hans D Saeger

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Who profits from neoadjuvant radiochemot

✍ Hany Elsaleh; James J Farrell; Christopher H Crane 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB

Patients with Locally Advanced Esophagea

✍ Guillaume Piessen; Nicolas Briez; Jean-Pierre Triboulet; Christophe Mariette 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 261 KB

Effects of neoadjuvant radiochemotherapy

✍ X.-F. Cao; X.-T. He; L. Ji; J. Xiao; J. Lv 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

596 Poster Neoadjuvant radiochemotherapy

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 301 KB

Results of Neoadjuvant Chemoradiation Th

✍ Murakami, Y.; Nobuki, I.; Doi, Y.; Okabe, T.; Kenjo, M.; Kaneyasu, Y.; Kimura, T 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Survival outcomes of resected patients w

✍ Z. T. Hammoud; K. A. Kesler; M. K. Ferguson; R. J. Battafarrano; A. Bhogaraju; N 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB